Status:

TERMINATED

Effect of Different Iloprost Doses on Symptoms in Systemic Sclerosis

Lead Sponsor:

Charite University, Berlin, Germany

Collaborating Sponsors:

Schering-Plough

Conditions:

Systemic Sclerosis

Eligibility:

All Genders

18-80 years

Phase:

PHASE2

Brief Summary

This study compared the efficacy of different dosages of long-term iloprost treatment on Raynaud's phenomenon, ulcer healing, skin thickening, and progression of internal organ sclerosis in systemic s...

Detailed Description

50 SSc patients (23 patients with limited SSc; 15 patients with diffuse SSc, and 12 patients with overlap syndromes fulfilling the ACR criteria for systemic sclerosis) and suffering from severe Raynau...

Eligibility Criteria

Inclusion

  • patients with secondary Raynaud's phenomenon suffering from severe Raynaud-'s phenomenon with trophical changes or from digital ulcers with written informed consent. Patients had to be stable for their systemic disease and were on stable medication concerning immunosuppression or vasoactive therapies for three months.

Exclusion

  • Current smokers, patients with a history of gastric ulcers in the last three months, a cardiac ejection fraction below 25%, patients with severe organ involvement or other uncontrolled diseases such as instable angina pectoris, severe anaemia, coagulopathies, azothaemia, cerebral stroke in the last 6 months or malignant diseases were excluded from the study. The last iloprost therapy had to be finished at least 6 months ago. Participation in other studies during the last 4 weeks was also not allowed. For fertile women, a negative pregnancy test was required.

Key Trial Info

Start Date :

September 1 1997

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2007

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT00622687

Start Date

September 1 1997

End Date

December 1 2007

Last Update

February 25 2008

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Charrité Universitätsmedizin

Berlin, State of Berlin, Germany, 10117